Impact of Increased Number of Biopsies on the Nature of Prostate Cancer Identified
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 176 (1), 63-69
- https://doi.org/10.1016/s0022-5347(06)00493-9
Abstract
Increasing the number of cores obtained at the time of transrectal ultrasound guided prostate biopsy has increased the number of cancers identified. However, there is increasing recognition that many men with prostate cancer may not benefit from early, aggressive intervention and that over detection of prostate cancer has resulted in over treatment. We determined the impact of the greater number of prostate biopsies on the nature of cancer identified. In the Cancer of the Prostate Strategic Urologic Research Endeavor database, a longitudinal disease registry of men with prostate cancer, we identified those men diagnosed between 1999 and 2002 with complete data on serum prostate specific antigen, Gleason score, clinical T stage, number of biopsies obtained and number involved with cancer. We identified 4,072 men with 6 or more prostate biopsies obtained at initial diagnosis. Of the men 30%, 47% and 24% underwent 6, 7 to 11, and more than 12 biopsies, respectively. The number of biopsies correlated significantly with numerous sociodemographic and clinical variables including prostate specific antigen, comorbidities and income. There did not appear to be differences in disease characteristics as assessed by Kattan and Cancer of the Prostate Risk Assessment scores among men with a biopsy number between 6 and 17. In the subset of 1,548 men undergoing radical prostatectomy, no differences in biochemical-free survival were observed among the various biopsy groups at a median followup of 2.2 years. The increasing number of prostate biopsies obtained at diagnosis increases cancer detection but the impact on disease characteristics remains unclear. Our data suggest that the risk stratification of prostate cancers is independent of biopsy number (6 or greater) in a contemporary cohort of men.Keywords
This publication has 16 references indexed in Scilit:
- THE INDEPENDENT IMPACT OF EXTENDED PATTERN BIOPSY ON PROSTATE CANCER STAGE MIGRATIONJournal of Urology, 2005
- THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMYJournal of Urology, 2005
- 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate CancerJAMA, 2005
- Natural History of Early, Localized Prostate CancerJAMA, 2004
- THE CONTEMPORARY MANAGEMENT OF PROSTATE CANCER IN THE UNITED STATES: LESSONS FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR (CAPSURE), A NATIONAL DISEASE REGISTRYJournal of Urology, 2004
- Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CaPSURE databaseUrology, 2000
- THE OPTIMAL SYSTEMATIC PROSTATE BIOPSY SCHEME SHOULD INCLUDE 8 RATHER THAN 6 BIOPSIES: RESULTS OF A PROSPECTIVE CLINICAL TRIALJournal of Urology, 2000
- A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGYJournal of Urology, 2000
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the ProstateJournal of Urology, 1989